Biofil Chem & Pharma Share Price

₹ 29.07

+₹0.39 (1.36%)
1D
Last updated 02 Nov, 2026, 15:54 IST
NSE: BIOFILCHEM
|
Pharmaceuticals

Biofil Chem & Pharma Share Price Today

As of 3 Nov 2026, Biofil Chem & Pharma share price is ₹29.07. The stock opened at ₹29.90, compared to its previous close of ₹28.68. During today's trading session, Biofil Chem & Pharma share price moved in the range of ₹28.42 to ₹29.90, with an average price of ₹29.16 for the day. Looking at its last 52-week, the stock has touched a low of ₹25.60 and a high of ₹46.34. On the performance front, Biofil Chem & Pharma share price has declined by 14.63% over the last six months and is down 26.85% on a year-on-year basis.

Share price over the last 1 day fell from 29.90 to 29.39, ranging between 28.42 and 29.90.
₹28.42
1.36% up today
₹29.90
1D LOW
1D HIGH

Biofil Chem & Pharma Stock Insights

Stock Performance
UnderperformingUnderperforming Nifty by 17.4 % in last 1 yr
Biofil Chem & Pharma stock performance
Open₹29.90
High₹29.90
Low₹28.42
Prev. close₹28.68
Biofil Chem & Pharma trading activity
Volume3,611
Average traded price₹29.33
Last traded time03:54:20 02 Nov
Last traded quantity15
Circuit
L
H
₹22.95
₹34.41
52-week
L
H
₹25.60
₹46.34
Mkt Cap Cr
47.18
P/E
96.67
P/B
2.19
ROA
1.12%
ROE
12.92%
ROCE
14.07%
Quick Ratio
1.54
EV/EBITDA
42.53

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Biofil Chemicals has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Biofil Chemicals appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Biofil Chem & Pharma Company Background

ISIN
INE829A01014
Sector Market Cap
₹ 47.18 Cr

Biofil Chemicals and Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing and trading pharmaceutical products. The Company operates through two segments: the Pharmaceutical Division and the Chemicals Division. It is also involved in the business activity of producing plastic products, which are used for the purpose of packing pharmaceutical product and other plastic products. The Company’s product categories include Basic Drugs & Chemicals, and Plastic Dripper & Caps. Its Basic Drugs & Chemicals include Sodium Chloride, Potassium Chloride, Sodium Citrate, Diethyl Carbamazine Citrate, Ferrous Sulphate, Dried Ferrous Sulphate, Ferrus Fumerate, Micro Crystalline Cellulose and Dicyclomine Hydrochloride. The Company's plants are located at Kheda Industrial Estate, Pithampur District, Dhar, and Sanwer Road, Industrial Area, Indore in Madhya Pradesh. The Company also deals in providing job work facilities in respect of the manufacturing of pharmaceutical drugs.

Biofil Chem & Pharma Financial Highlights

  • Revenue: Biofil Chem & Pharma reported revenue of ₹31.48 crore in FY26 vs ₹33.71 crore in FY25. It showed a decrease of 6.62% on a yearly basis.
  • Operating Profit: Biofil Chem & Pharma reported an operating profit of ₹3.45 crore in FY26 vs ₹0.74 crore in FY25. It showed an increase of 366.22% on a year-on-year basis.
  • Net Profit: Biofil Chem & Pharma reported a net profit of ₹2.79 crore in FY26 vs ₹0.56 crore in FY25. It showed an increase of 398.21% on a yearly basis.

Biofil Chem & Pharma Quarterly Result Highlights

  • Biofil Chem & Pharma reported revenue of ₹12.41 crore in Jun 2026, compared with ₹7.68 crore in Mar 2026, representing an increase of 61.59% on a quarter-on-quarter (QoQ) basis.
  • Biofil Chem & Pharma reported an operating profit of ₹0.13 crore in Jun 2026, compared with ₹0.47 crore in Mar 2026, representing a decrease of 72.34% on a quarter-on-quarter (QoQ) basis.
  • Biofil Chem & Pharma reported a profit of ₹0.11 crore in Jun 2026, compared with ₹0.21 crore in Mar 2026, reflecting a decrease of 47.62% on a QoQ basis.
  • The earnings per share (EPS) of Biofil Chem & Pharma stood at ₹1.71 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
46.79%
FII
0.00%
Other DII
0.08%
Retail and other
53.13%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

Biofil Chem & Pharma Investment Returns

1 day
+1.36%
1 week
+3.71%
1 month
-0.82%
1 year
-26.85%
3 years
-40.79%
5 years
-53.45%

Biofil Chem & Pharma Share Price History

Biofil Chem & Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹29.90 / ₹29.07
+1.36%
30 Oct 26
₹29.00 / ₹28.68
-2.48%
29 Oct 26
₹29.00 / ₹29.41
+0.51%
28 Oct 26
₹29.80 / ₹29.26
-2.21%
Show more

Biofil Chem & Pharma Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹28.40₹33.40₹40.04₹30.04
Other Income₹3.08₹0.31₹0.49₹0.10
Total Revenue₹31.48₹33.71₹40.53₹30.13
Total Expenses₹28.03₹32.97₹39.66₹29.34
Profit Before Tax₹3.45₹0.74₹0.87₹0.79
Tax₹0.66₹0.18₹0.16₹0.23
Profit After Tax₹2.79₹0.56₹0.71₹0.56
EPS - Basic₹1.71₹0.34₹0.44₹0.34
EPS - Diluted₹1.71₹0.34₹0.44₹0.34

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹3.45₹0.74₹0.87₹0.79
Income before WC changes₹3.73₹1.17₹1.50₹1.17
Change in Assets₹9.77-₹6.19-₹13.81-₹13.20
Change in Liabilities-₹13.44₹3.27₹14.86₹12.15
Change in WC-₹3.67-₹2.92₹1.05-₹1.05
Cash flow from Operations-₹0.60-₹1.92₹2.39-₹0.11
Cash flow from Investing₹1.14-₹0.10-₹0.02-₹0.01
Cash flow from Financing₹2.54₹0.00-₹0.12₹0.02
Total Cash Flow₹3.07-₹2.03₹2.25-₹0.11
Cash (Start of the year)₹0.26₹2.28₹0.04₹0.14
Cash (End of the year)₹3.33₹0.26₹2.28₹0.04

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹6.99₹8.41₹8.68₹9.05
Current Assets₹35.86₹42.55₹38.41₹22.35
Total Assets₹42.85₹50.96₹47.08₹31.41
Current Liabilities₹20.69₹31.85₹28.52₹13.73
Net Current Asset₹15.17₹10.71₹9.88₹8.63
Non-Current Liabilities₹0.59₹0.33₹0.36₹0.38
Equity Capital₹21.56₹18.78₹18.20₹17.30
Total Equity & Liabilities₹42.85₹50.96₹47.08₹31.41
* All values are in INR Crore
Biofil Chem & Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
0029.07185
0000
0000
0000
0000
Total bid quantity0
Total ask quantity185
Biofil Chem & Pharma technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
40.13
Neutral
ATR (14)
1.47
Neutral
STOCH(9,6)
35.08
Neutral
STOCH RSI (14)
58.09
Neutral
ADX(9)
17.47
Bullish
UO(9)
43.6
Neutral
ROC(12)
-4.97
Bearish
WillR(14)
-65.73
Neutral
Period
Simple value
Exponential vaue
5D
29.06
29.1
10D
29.32
29.32
20D
29.66
29.83
50D
31.27
30.93
100D
32.54
31.79
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Biofil Chem & Pharma
Pharmaceuticals
Add Stock
Add Another

Biofil Chem & Pharma Share Price FAQs

Please be aware that Biofil Chem & Pharma stock prices are subject to continuous fluctuations due to various factors.